Globus Medical Inc - Ordinary Shares - Class A

Globus Medical Inc - Ordinary Shares - Class A

GMED - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$9.54B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Globus Medical Inc - Ordinary Shares - Class AGlobus Medical Inc - Ordinary Shares - Class A17.2-12%3.1-
$86.25

Target Price by Analysts

19.6% upsideGlobus Medical Target Price DetailsTarget Price
$229.79

Current Fair Value

218.5% upside

Undervalued by 218.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$9.54 Billion
Enterprise Value$9.24 Billion
Earnings per Share$3.98
Beta0.96
Outstanding Shares134,150,000

Return

Return on Equity11.63%ROE
Return on Assets10.09%
Return on Invested Capital13.89%

Valuation & Multiples

P/E Ratio17.16P/E Ratio
PEG91.95PEG
Price to Sales3.14Price to Sales
Price to Book Ratio2.06Price to Book Ratio
Enterprise Value to Revenue2.94
Enterprise Value to EBIT13.25
Enterprise Value to Net Income16
Total Debt to Enterprise0.02
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 10, 2026
EPS Estimate
$1.18
Consensus analyst estimate
Revenue Estimate
$791.62 M
Consensus analyst estimate

Next Earnings Call

Expected Date
February 23, 2027
EPS Estimate
$1.30
Consensus analyst estimate
Revenue Estimate
$783.40 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 19.40%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %17.31%▼ 71.50%
Total Invested$1.75B▼ 81.59%
Investors Holding295▼ 323.00%

About Globus Medical Inc

CEO: David Demski

Globus Medical Insider Information FAQ

Stockcircle tracks 7 top investors with a current 13F position in Globus Medical. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 2 top investors increased or opened positions and 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 3 open-market insider sales for Globus Medical in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Stockcircle lists 3 politician trade disclosures tied to Globus Medical in the last twelve months, drawn from periodic financial disclosure reports. 1 politician traded Globus Medical in the past year.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.